Limb girdle musc dyst due to other sarcoglycan dysfunction

This code identifies a specific type of limb-girdle muscular dystrophy (LGMD) characterized by progressive weakness and wasting of muscles around the hips and shoulders. The underlying cause is a genetic defect affecting sarcoglycan proteins, excluding those specifically linked to alpha, beta, gamma, or delta sarcoglycanopathies.

Use this code for patients diagnosed with LGMD where genetic testing or clinical presentation points to a sarcoglycanopathy not otherwise specified by a more precise sarcoglycan gene defect. Documentation should clearly state "limb-girdle muscular dystrophy" and specify "other sarcoglycan dysfunction" as the etiology.

• Ensure documentation differentiates this from LGMD due to specific alpha, beta, gamma, or delta sarcoglycan deficiencies, which have their own distinct codes.
• Avoid using this code if the specific sarcoglycan gene (e.g., SGCA, SGCB, SGCG, SGCD) is identified; instead, use the more precise code.
• Always review genetic testing results or physician notes for the exact type of sarcoglycan involvement to ensure the most specific code is chosen.